According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
Commemorations took place yesterday in Nice to mark the anniversary of the attack in July 2016 in which 86 people lost their lives...
Read More
French TV host and producer Thierry Ardisson has died in Paris at the age of 76 from liver cancer, his family announced. ...
Read More
An administrative judge has suspended an order against large cruise ships in Villefranche-sur-mer and Nice. Nice Mayor and President of the Nice Cote ...
Read More
The prefect of the Alpes-Maritimes has made a legal challenge against new limits on large cruise ship moorings in Nice and Villefranche....
Read More
British Prime Minister Sir Keir Starmer and President Emmanuel Macron have announced a so-called "one in, one out" migrant deal aimed at reducing migr...
Read More
